<DOC>
	<DOCNO>NCT00523770</DOCNO>
	<brief_summary>GSK Biologicals work development vaccine protect elderly people pneumococcal infection . For future study project , would useful easy non invasive test detect infection bacteria . Some test urine already market need improve laboratory . For purpose , urine sample healthy subject age 65 year suffer pneumonia administer pneumococcal vaccination past 3 month need . The Protocol Posting update order comply FDA Amendment Act , Sep 2007</brief_summary>
	<brief_title>Exploratory Study Healthy Elderly Subjects Collect Urine Development Assays Detect S. Pneumoniae</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Streptococcal Infections</mesh_term>
	<criteria>Subjects investigator believe comply requirement protocol enrol study . A male female , include , 65 85 year age time study . Written inform consent obtain subject Healthy subject establish medical history clinical examination enter study Previous vaccination Streptococcus pneumoniae 3 month study start , History pneumonia confirm documented radiology diagnostic method within 3 month prior study start</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Invasive Pneumococcal Diseases</keyword>
	<keyword>Pneumonia</keyword>
</DOC>